Chemoprotection against cytosine nucleoside analogs using the human cytidine deaminase gene.
Eliopoulos
N
N
Département de pharmacologie, Université de Montréal, Hôpital Ste-Justine, Québec, Canada.
Beauséjour
C
C
Momparler
R L
RL
D000964:Antimetabolites, Antineoplastic / Q000009:adverse effects*; D001374:Azacitidine / Q000009:adverse effects / Q000031:analogs & derivatives; D003561:Cytarabine / Q000009:adverse effects; D003564:Cytidine Deaminase / Q000235:genetics*; D000077209:Decitabine; D003841:Deoxycytidine / Q000009:adverse effects / Q000031:analogs & derivatives; D004351:Drug Resistance / Q000235:genetics; D006801:Humans; D000093542:Gemcitabine
D000964:Antimetabolites, Antineoplastic; D003561:Cytarabine; D003841:Deoxycytidine; D000077209:Decitabine; D003564:Cytidine Deaminase; D001374:Azacitidine; D000093542:Gemcitabine